ScoreWhy is Welcure Drugs & Pharmaceuticals Ltd ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 13.46% of over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 9.73 times
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Welcure Drugs for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Welcure Drugs
-48.56%
-0.84
57.89%
Sensex
9.35%
0.80
11.65%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
91.10%
EBIT Growth (5y)
13.46%
EBIT to Interest (avg)
8.98
Debt to EBITDA (avg)
123.20
Net Debt to Equity (avg)
1.20
Sales to Capital Employed (avg)
0.11
Tax Ratio
23.80%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-3.09%
ROE (avg)
4.93%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
1
Industry P/E
32
Price to Book Value
0.42
EV to EBIT
3.86
EV to EBITDA
3.86
EV to Capital Employed
0.74
EV to Sales
0.43
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.98%
ROE (Latest)
34.54%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend18What is working for the Company
NET SALES(Latest six months)
At Rs 65.62 cr has Grown at 158.04%
PAT(Latest six months)
At Rs 9.57 cr has Grown at 409.04%
-6What is not working for the Company
PAT(Q)
At Rs 1.07 cr has Fallen at -87.6% (vs previous 4Q average
PBDIT(Q)
Lowest at Rs -0.03 cr.
PBT LESS OI(Q)
Lowest at Rs -0.03 cr.
NON-OPERATING INCOME(Q)
is 102.10 % of Profit Before Tax (PBT
Loading Valuation Snapshot...
Here's what is working for Welcure Drugs
Net Sales - Latest six months
At Rs 65.62 cr has Grown at 158.04%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (Rs Cr)
Here's what is not working for Welcure Drugs
Profit After Tax (PAT) - Quarterly
At Rs 1.07 cr has Fallen at -87.6% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 8.60 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs -0.03 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs -0.03 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
Non Operating Income - Quarterly
is 102.10 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
